The Centers for Medicare and Medicaid Services (CMS) has released the first 10 drugs selected for Medicare price negotiation. This is a significant provision under the Inflation Reduction Act that allows Medicare to negotiate lower prescription drug costs for seniors and other beneficiaries. The move is a major step forward in the Biden administration's efforts to lower healthcare costs and make medications more affordable. The drugs selected for negotiation include treatments for diabetes, heart disease, arthritis, blood clots, and cancers. Up to 9 million Americans are expected to benefit from the new negotiated drug prices. This is a historic milestone that will provide relief for millions of people who have been struggling to afford life-saving medications. The announcement has been met with positive reactions from members of Congress, healthcare advocates, and various organizations.